Ignite Creation Date:
2024-05-06 @ 3:57 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02413671
Status:
COMPLETED
Last Update Posted:
2016-10-13
First Post:
2015-03-24
Brief Title:
The Role of Whey and Lupin in Glycemic Control Nutritional Pre-Study
Sponsor:
DLR German Aerospace Center
Organization:
DLR German Aerospace Center
Study Overview
Official Title:
Short-term Effects of Lupin Versus Whey Protein on Glucose and Insulin Responses to a Standardized Meal in a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
NPS
Brief Summary:
The study compared the acute effects of the supplementation of a standardized meal with either lupin or whey protein or no protein on the whole-body glucose and insuline metabolism
Detailed Description:
The nutritional pre-study had the following key objectives
Primary objective
- Lupin protein lowers the postprandial blood glucose level equivalent to or to a greater extent than whey protein
Secondary objective
- Lupin protein has an equivalent or a stronger insulinotropic effect than whey protein
Primary objective
- Lupin protein lowers the postprandial blood glucose level equivalent to or to a greater extent than whey protein
Secondary objective
- Lupin protein has an equivalent or a stronger insulinotropic effect than whey protein
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None